| |
|
|
| Name: |
Omega Fund Management (US) Inc. |
| City: |
BOSTON |
| State: |
MA |
| Zip: |
02116 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
11 |
|
View All Holdings |
Currently
Viewing:
Unchanged Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
REPL |
Replimune Group Inc |
2 |
- |
$6.81 |
$25,301,000 |
3,001,319 |
20.5% |
-26,052,000 |
0 |
5.298 |
N/A |
|
|
NUVB |
Nuvation Bio Ord Shs Class A |
3 |
- |
$10.42 |
$22,759,000 |
15,072,340 |
18.44% |
2,562,000 |
0 |
6.957 |
N/A |
|
|
MORF |
Morphic Holding, Inc. |
5 |
- |
$30.23 |
$8,948,000 |
309,846 |
7.25% |
1,849,000 |
0 |
0.805 |
N/A |
|
|
SPRB |
Spruce Biosciences, Inc. |
6 |
- |
$0.00 |
$6,332,000 |
2,161,022 |
5.13% |
1,448,000 |
0 |
5.785 |
N/A |
|
|
KRON |
Kronos Bio, Inc. |
7 |
- |
$0.00 |
$4,773,000 |
3,818,283 |
3.87% |
-191,000 |
0 |
6.815 |
N/A |
|
|
IKNA |
Ikena Oncology, Inc. |
8 |
- |
$0.00 |
$4,431,000 |
2,249,123 |
3.59% |
-5,308,000 |
0 |
7.467 |
N/A |
|
|
SANA |
Sana Biotechnology, Inc. |
9 |
- |
$0.00 |
$3,443,000 |
843,750 |
2.79% |
178,000 |
0 |
0.45 |
N/A |
|
|
THRX |
Theseus Pharmaceuticals, Inc. |
10 |
- |
$0.00 |
$2,881,000 |
711,479 |
2.33% |
967,000 |
0 |
1.674 |
N/A |
|
|
IMUX |
Immunic Inc |
11 |
- |
$1.30 |
$2,682,000 |
1,788,160 |
2.17% |
53,000 |
0 |
4.031 |
N/A |
|
|
SYRS |
Syros Pharmaceuticals, Inc. |
12 |
- |
$5.51 |
$1,957,000 |
251,270 |
1.59% |
964,000 |
0 |
0.447 |
N/A |
|
|
SNTI |
Senti Biosciences, Inc |
13 |
- |
$0.38 |
$129,000 |
195,792 |
0.1% |
48,000 |
0 |
0.448 |
N/A |
|
